- Open Access
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Journal of Hematology & Oncology volume 14, Article number: 31 (2021)
- The original article was published in Journal of Hematology & Oncology 2020 13:173
Correction to: J Hematol Oncol (2020) 13:173 https://doi.org/10.1186/s13045-020-01007-9
The original article contains an incorrect affiliation for co-author, Meike Vogler. The correct affiliation can be viewed in this Correction article.
Bolomsky A, et al. MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol. 2020;13:173. https://doi.org/10.1186/s13045-020-01007-9.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bolomsky, A., Vogler, M., Köse, M.C. et al. Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol 14, 31 (2021). https://doi.org/10.1186/s13045-021-01043-z